Antiviral Drugs Market By Drug Type (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors, Integrase Inhibitors, Entry Inhibitors, Fusion Inhibitors, Others), By Virus Type (HIV, Hepatitis B and C, Influenza, Herpes Simplex Virus, Respiratory Syncytial Virus, Others), By Therapeutic Application (Prophylactic, Curative, Symptomatic Treatment, Others), By Route of Administration (Oral, Injectable, Topical, Intranasal), By End-User (Hospitals, Clinics, Home Care Settings, Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Type

• Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Protease Inhibitors (PIs)
• Integrase Inhibitors
• Entry Inhibitors
• Fusion Inhibitors
• Others

By Virus Type

• HIV
• Hepatitis B and C
• Influenza
• Herpes Simplex Virus (HSV)
• Respiratory Syncytial Virus (RSV)
• Others

By Therapeutic Application

• Prophylactic
• Curative
• Symptomatic Treatment
• Others

By Route of Administration

• Oral
• Injectable
• Topical
• Intranasal

By End-User

• Hospitals
• Clinics
• Home Care Settings
• Research Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Gilead Sciences, Inc.
• GlaxoSmithKline
• AbbVie Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb
• Johnson & Johnson
• AstraZeneca
• Roche Holding AG
• Novartis AG
• Sofinnova Partners
• Horizon Therapeutics
• ViiV Healthcare
• Eisai Co., Ltd.
• Aicuris Anti-infective Cure
• Kissei Pharmaceutical Co., Ltd.